Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. - Wikidata - awgldk - TriplyDB

Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study.

Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study.

http://www.wikidata.org/entity/Q45162616

about

Management of Membranous Nephropathy in Western Countries Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases Urine proteomic profiling of pediatric nephrotic syndrome.Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathy.Controversies in the treatment of idiopathic membranous nephropathy.Approaching biomarkers of membranous nephropathy from a murine model to human disease.Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography TRPC6 single nucleotide polymorphisms and progression of idiopathic membranous nephropathy Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study.A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study.Pharmacological treatment of primary membranous nephropathy in 2016.Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study.Glomerular and tubular damage markers in individuals with progressive albuminuria.American Society of Nephrology Quiz and Questionnaire 2012: glomerulonephritis Urinary IgG and α2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy Novel biomarkers in glomerular disease.A novel link: in children, cow milk processing may be causative of idiopathic membranous nephropathy.ADME of monoclonal antibody biotherapeutics: knowledge gaps and emerging tools.Biomarkers in the assessment of acute and chronic kidney diseases in the dog and cat.Comparative proteomic analysis of membranous nephropathy biopsy tissues using quantitative proteomics.Novel Biomarkers for Renal Diseases? None for the Moment (but One).The role of novel biomarkers in childhood idiopathic nephrotic syndrome: a narrative review of published evidence.Beta2-microglobulin as a diagnostic marker in cerebrospinal fluid: a follow-up study.Clinical role of urinary low molecular weight proteins: their diagnostic and prognostic implications.Long-term outcomes of persistent disease and relapse in primary membranous nephropathy.Is the urinary protein excretion pattern compatible with renal morphological findings in renal amyloidosis?Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy.Is the reno-protective effect of valsartan dose dependent? A comparative study of 80 and 160 mg day(-1).High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.Urinary Biomarkers of Renal Disease in Dogs with X-Linked Hereditary Nephropathy Clinical implications of pathological features of primary membranous nephropathy

P2860

Q26740477-6A9BA104-F7C7-4154-B555-D35216309450 Q26773607-0EAA40D1-D491-43CA-A7A4-FD0FA4A14F82 Q33248438-9AE094B6-1E33-4FF2-9B71-5DF5B3F9153A Q33600782-CE3A90BF-18A5-4C88-AE02-6EFF47E0027F Q33715801-B3D1AEB2-BF5A-4D75-AC9E-3987407F0F92 Q34248343-500922CA-C590-4EE3-8F03-D1F0908D963B Q34479273-0A6AB113-ECAC-4B4B-895E-08BDFFD195B2 Q35030567-38D286B5-0D4B-4385-BBA5-0F2458761194 Q35067364-DC296493-20B1-43C4-A903-5071AF0CCFCC Q35206224-879833C4-BCFF-4C9E-839B-6AE694FC891E Q35664611-AF18C3A9-AE91-4974-A4DB-7547FA9AC261 Q35840057-4D8ADA1D-B9CC-4882-9CFE-ABA5BC5352BE Q36088887-0E2D90A4-8138-42D2-82FC-900B818078A8 Q36106413-ABD805D9-88B7-461C-BFD6-081C698A43A4 Q36126897-6FB40F02-070C-43A6-87F1-4710537E1F6E Q36741001-CF82811B-C7BE-4A70-A61E-91C9A4C187E6 Q36980313-D32B2A1A-4119-43B3-A63B-2542F34E7BAD Q37065581-152D39EA-D2AD-482D-9657-697EE2B7BD7A Q37182778-24F98401-79D1-499A-B00F-C47B3EF4030F Q37411651-8828C06C-FCE6-4EEE-BB3D-6461379DDCD3 Q37658483-26E3394D-8947-427E-9A06-751AC0A445DD Q37970010-87C41638-6378-489A-BD5E-19DDCC5CE8DF Q38128342-C6EAE819-26A8-4CE4-898D-76354438C866 Q38154953-6380F925-ABCA-4B2D-BCE9-00C6B5DE7D75 Q38466973-2B285258-716B-4472-A807-ABF69498D3AC Q38763898-64883412-9297-499A-9A73-0F555D9D4D01 Q39374379-B6B331BA-47E8-4900-A315-23B82B1A8C4B Q39957314-DE351489-7220-4F78-9E49-ADDA3698232C Q40057864-FAEC10FC-8B5B-4D46-9C25-4C7F60166324 Q40105860-48D46817-8DDB-4B47-892F-23AE01A386F8 Q40399650-3322E247-3B34-436D-AB0D-A36EE73CBA9B Q42155627-0D66E1FA-2AE1-4289-B020-4192819B1A02 Q43016390-48496047-7E1C-46E0-B7E7-9AF28987719A Q45236430-9D3D7A48-7D2D-4E59-BDFE-21EEF017158F Q51213724-6CE88658-4FDC-4428-9C27-232DA13AF3FE Q57432371-4ED43D4A-DA08-41C7-8593-7F3FB06EC5AC Q58699151-6736B2CB-B42A-41FF-8189-D44467A49169

P2860

Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study.

http://www.wikidata.org/entity/Q45162616

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Urinary excretion of beta2-mic ...... phropathy: a validation study.

@en

Urinary excretion of beta2-mic ...... phropathy: a validation study.

@nl

type

label

Urinary excretion of beta2-mic ...... phropathy: a validation study.

@en

Urinary excretion of beta2-mic ...... phropathy: a validation study.

@nl

prefLabel

Urinary excretion of beta2-mic ...... phropathy: a validation study.

@en

Urinary excretion of beta2-mic ...... phropathy: a validation study.

@nl

P1433

Q45162616-B69FDF60-3B62-479E-976B-FB717D4683C3

P1476

Q45162616-81FC83A8-76C6-4E16-8302-D76B0A9B7B55

P2093

Q45162616-0EB71BAD-B3C5-4824-AC08-72F56CBE4E7D

Q45162616-1D8D924F-2221-42A4-8C8A-71046868AB43

Q45162616-2ADB86FE-2A31-4703-857B-F7B29E87D6DB

Q45162616-3893CBF4-F347-418B-B2DE-FC74235C6FF1

Q45162616-5A0ABE48-69EE-4C9C-82C2-896424120F7F

Q45162616-7E83DC83-C180-443E-8D59-29482727BC54

Q45162616-FBBB51AF-DAA1-40E8-AB49-144582FCEFA1

P304

Q45162616-E057ED83-B8F8-49EF-9366-506E1BBBD278

P31

Q45162616-04E71DEF-6893-441C-B437-0E96B60FE119

P356

Q45162616-80712A67-6D3E-4908-A831-56A3E3B9F1F0

P433

Q45162616-B5150C1A-A713-46EB-A540-4F2C8D4910F2

P478

Q45162616-82D28813-C0AF-4064-A81F-F0D1FC209214

P577

Q45162616-3F3FC3C0-0ABB-4499-BB59-11691B16B2F3

P698

Q45162616-C8FF4ECB-5B0E-4E24-B6E3-0476C4658300

P356

P1433

Journal of the American Society of Nephrology

P1476

Urinary excretion of beta2-mic ...... phropathy: a validation study.

@en

P2093

Amanda J W Branten

http://www.w3.org/2001/XMLSchema#string

Daan A Hollander

http://www.w3.org/2001/XMLSchema#string

Frank H Bosch

http://www.w3.org/2001/XMLSchema#string

Geert W Feith

http://www.w3.org/2001/XMLSchema#string

Ina S Klasen

http://www.w3.org/2001/XMLSchema#string

Jack F Wetzels

http://www.w3.org/2001/XMLSchema#string

Peggy W du Buf-Vereijken

http://www.w3.org/2001/XMLSchema#string

P304

169-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2004040287

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15563570

http://www.w3.org/2001/XMLSchema#string